» Articles » PMID: 26322515

Sex- and Time-Dependent Patterns in Risk Factors of End-Stage Renal Disease: A Large Austrian Cohort with Up to 20 Years of Follow-Up

Overview
Journal PLoS One
Date 2015 Sep 1
PMID 26322515
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We investigated the association between metabolic factors and End-Stage Renal Disease (ESRD) and quantified the magnitude of their influence dependent on sex and time of exposure up to 20 years.

Material And Methods: A prospective cohort study was conducted to determine risk factors for the development of ESRD. From 1988 to 2005 185,341 persons (53.9% women) participated in the "Vorarlberg Health Monitoring and Promotion Programme" (VHM&PP). Data on body mass index (BMI), fasting blood glucose (FBG), systolic (BPsys) and diastolic (BPdia) blood pressure, total cholesterol (TC), triglycerides (TG), gamma-glutamyltransferase (GGT) and smoking status were collected. Data of the population-based VHM&PP were merged with the Austrian Dialysis and Transplant Registry. Cox proportional hazards models were applied to calculate hazard ratios (HRs) for ESRD, stratified by sex and 5-year time intervals.

Results: During a mean follow-up of 17.5 years 403 patients (39.1% women) developed ESRD. Significant risk factors were: BMI (per 1 kg/m2) HR 1.04 (95% CI 1.01-1.06), FBG (per 1 mmol/L) HR 1.09 (1.05-1.12), BPsys (per 5 mmHg) HR 1.10 (1.07-1.14), BPdia (per 5 mmHg) HR 1.09 (1.03-1.15), TG (per 1 mmol/L) HR 1.07 (1.02-1.13), TC (per 1 mmol/L) HR 1.22 (1.13-1.32). We observed a sex-specific risk pattern with an increased ESRD risk for men for increasing TG and smoking, and for women for increasing BMI and GGT. In time interval analyses BPsys and TC were associated with early ESRD onset, whereas BMI, FBG, BPdia and GGT were associated with later onset.

Conclusions: Anthropometric and metabolic factors are differentially associated with the long-term risk for ESRD in a sex- and time-dependent manner. Consideration of these patterns in preventive and therapeutic strategies could have an impact on ESRD incidence.

Citing Articles

Association of Smoking with Chronic Kidney Disease Stages 3 to 5: A Mendelian Randomization Study.

Zhang Z, Zhang F, Zhang X, Lu L, Zhang L Health Data Sci. 2024; 4:0199.

PMID: 39498379 PMC: 11532587. DOI: 10.34133/hds.0199.


The hidden impact: the rate of nicotine metabolism and kidney health.

Wang X, Su S Front Endocrinol (Lausanne). 2024; 15:1424068.

PMID: 39355620 PMC: 11442274. DOI: 10.3389/fendo.2024.1424068.


Gender disparity in maintenance hemodialysis units in South India: a cross-sectional observational study.

Shankar M, Satheesh G, A K, C G S, Reddy G Front Nephrol. 2024; 4:1322003.

PMID: 38590819 PMC: 10999745. DOI: 10.3389/fneph.2024.1322003.


A quality improvement initiative for patients with chronic kidney disease to promote their smoking cessation.

Chen C, Lin T, Hung S, Wu M, Tsai S Tob Induc Dis. 2023; 21:127.

PMID: 37818037 PMC: 10561597. DOI: 10.18332/tid/170626.


Non-traditional risk factors of progression of chronic kidney disease in adult population: a scoping review.

Cisneros-Garcia D, Sandoval-Pinto E, Cremades R, Ramirez-de-Arellano A, Garcia-Gutierrez M, Martinez-de-Pinillos-Valverde R Front Med (Lausanne). 2023; 10:1193984.

PMID: 37332753 PMC: 10272583. DOI: 10.3389/fmed.2023.1193984.


References
1.
Ulmer H, Kelleher C, Diem G, Concin H . Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme. Eur Heart J. 2003; 24(11):1004-13. DOI: 10.1016/s0195-668x(03)00170-2. View

2.
. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106(25):3143-421. View

3.
Wimmer F, Oberaigner W, Kramar R, Mayer G . Regional variability in the incidence of end-stage renal disease: an epidemiological approach. Nephrol Dial Transplant. 2003; 18(8):1562-7. DOI: 10.1093/ndt/gfg184. View

4.
Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo Jr J . Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42(6):1206-52. DOI: 10.1161/01.HYP.0000107251.49515.c2. View

5.
Klag M, Whelton P, Randall B, Neaton J, Brancati F, Ford C . Blood pressure and end-stage renal disease in men. N Engl J Med. 1996; 334(1):13-8. DOI: 10.1056/NEJM199601043340103. View